Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
NeurogesX |
---|---|
Information provided by: | NeurogesX |
ClinicalTrials.gov Identifier: | NCT00034710 |
The purpose of this study is to gain initial information on the tolerability of high-dose capsaicin patches in patients with Painful Postherpetic Neuralgia. The study will also collect preliminary information on safety and efficacy.
Condition | Intervention | Phase |
---|---|---|
Neuralgia Pain Peripheral Nervous System Diseases Herpes Zoster |
Drug: Capsaicin Patch |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Dose Comparison, Safety/Efficacy Study |
Official Title: | A Double-Blind Controlled Pilot Study of High-Dose Capsaicin Patches in the Treatment of Pain Associated With Postherpetic Neuralgia |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Eligibility Criteria
Inclusion Criteria:
Patients may be eligible for this study if they:
Exclusion Criteria:
Patients will not be eligible for this study if they:
United States, Arizona | |
University of Arizona Health Sciences Center | |
Tucson, Arizona, United States, 85724 | |
Arizona Research Center | |
Phoenix, Arizona, United States, 85023 | |
United States, Florida | |
Suncoast Neuroscience Associates, Inc. | |
St. Petersburg, Florida, United States, 33701 | |
Anchor Research Center | |
Naples, Florida, United States, 34102 | |
Palm Beach Neurological Center | |
Palm Beach Gardens, Florida, United States, 33410 | |
United States, Massachusetts | |
Brigham and Women's Hospital, Pain Trials Center | |
Boston, Massachusetts, United States, 02115 | |
United States, Utah | |
University of Utah Pain Management Center | |
Salt Lake City, Utah, United States, 84108 | |
United States, Wisconsin | |
University of Wisconsin Hospital, Neurology Department | |
Madison, Wisconsin, United States, 53792 |
Study Director: | John A Jermano | NeurogesX |
Study ID Numbers: | C102 |
Study First Received: | May 1, 2002 |
Last Updated: | February 6, 2006 |
ClinicalTrials.gov Identifier: | NCT00034710 |
Health Authority: | United States: Food and Drug Administration |
Analgesics/*therapeutic use Capsaicin/*administration & dosage/adverse effects Herpes Zoster/*complications/drug therapy Neuralgia/*drug therapy/etiology Pain Capsicum Pepper Dermal assessment |
Pain measurement Diary PHN Postherpetic Neuralgia allodynia hyperalgesia shingles varicella |
Herpes Zoster Neuralgia, Postherpetic Neuralgia Chickenpox Pain Capsaicin Hyperalgesia Herpesviridae Infections |
Virus Diseases Signs and Symptoms Neuromuscular Diseases Peripheral Nervous System Diseases Neurologic Manifestations DNA Virus Infections Chicken pox |
Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Nervous System Diseases |
Antipruritics Peripheral Nervous System Agents Dermatologic Agents Pharmacologic Actions |